High-Dose Baclofen for Suppression of Alcohol Dependence

Alcoholism: Clinical and Experimental Research

Volumn 35, Issue 5, 2011, Pages 845-846

  Ameisen, Olivier ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; ALCOHOL; BACLOFEN; NALTREXONE; PLACEBO; TOPIRAMATE;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; CHILD; DRUG EFFICACY; DRUG FATALITY; DRUG MEGADOSE; DRUG SAFETY; HUMAN; LETTER; LOW DRUG DOSE; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; SPASTICITY; SYMPTOM; TREATMENT OUTCOME;

ALCOHOLISM; BACLOFEN; FEMALE; GABA AGONISTS; HUMANS; MALE;

EID: 79955482282     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2010.01412.x     Document Type: Letter

References (12)

1. Agabio R, Marras P, Addolorato G, Carpiniello B, Gessa GL (2007) Baclofen suppresses alcohol intake and craving for alcohol in a schizophrenic alcohol-dependent patient: a case report. J Clin Psychopharmacol 27:319-320.
2. Ameisen O (2005a) Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician. Alcohol Alcohol 40:147-150.
3. Ameisen O (2005b) Naltrexone treatment for alcohol dependency. JAMA 294:899-900, author reply 900.
4. Ameisen O (2007) Baclofen as a craving-suppressing agent. CNS Drugs 21:693.
5. Ameisen O (2009) Treatment of alcohol-use disorders. Lancet 373:1519.
6. Ameisen O, de Beaurepaire R (2010) Suppression of alcohol dependence using high-dose baclofen: an observational study. Ann Med Psychol 168:159-162.
7. Buckam W (2007) Suppression of symptoms of alcohol dependence and craving using high-dose baclofen. Alcohol Alcohol 42:158-160.
8. Garbutt JC, Kampov-Polevoy AB, Gallop R, Kalka-Juhl L, Flannery BA (2010) Efficacy and safety of baclofen for alcohol dependence: a randomized, double blind, placebo-controlled trial. Alcohol Clin Exp Res 34:1849-1857.
9. Greene P (1992) Baclofen in the treatment of dystonia. Clin Neuropharmacol 15:276-288. Review.
10. Greene PE, Fahn S (1992) Baclofen in the treatment of idiopathic dystonia in children. Mov Disord 7:48-52.
11. Heinz A, Beck A, Grüsser SM, Grace AA, Wrase J (2009) Identifying the neural circuitry of alcohol craving and relapse vulnerability. Addict Biol 14:108-118.
12. Smith CR, LaRocca NG, Giesser BS, Scheinberg LC (1991) High-dose oral baclofen: experience in patients with multiple sclerosis. Neurology 41:1829-1831.